Population pharmokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy

A.D.R. Huitema, R.A.A. Mathot, M.M. Tibben, J.H.M. Schellens, S. Rodenhuis, J.H. Beijnen

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	61-70
Number of pages	10
Journal	British Journal of Clinical Pharmacology
Volume	51
Publication status	Published - 2001

Cite this

@article{f38642c262c1413da145e30cff5564c9,

title = "Population pharmokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy",

author = "A.D.R. Huitema and R.A.A. Mathot and M.M. Tibben and J.H.M. Schellens and S. Rodenhuis and J.H. Beijnen",

year = "2001",

language = "Undefined/Unknown",

volume = "51",

pages = "61--70",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley-Blackwell Publishing Ltd",

}

TY - JOUR

T1 - Population pharmokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy

AU - Huitema, A.D.R.

AU - Mathot, R.A.A.

AU - Tibben, M.M.

AU - Schellens, J.H.M.

AU - Rodenhuis, S.

AU - Beijnen, J.H.

PY - 2001

Y1 - 2001

M3 - Article

SN - 0306-5251

VL - 51

SP - 61

EP - 70

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

ER -